BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35798893)

  • 1. Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy-A Chinese Multicenter Study.
    Deng ZJ; Lu J; Nie RC; Fang JM; Chen XJ; Liu JJ; Li XZ; Chen YB; Huang CM; Lian L; Peng JS; Chen S
    Ann Surg Oncol; 2022 Dec; 29(13):8214-8224. PubMed ID: 35798893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
    BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
    Zhang LK; Zheng HL; Zheng HH; Ma YB; Lin JX; Xu BB; Xue Z; Zheng ZW; Zheng CH; Huang CM; Xie JW
    Eur J Surg Oncol; 2024 Jun; 50(6):108367. PubMed ID: 38718701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Model of D2 Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Gastric Cancer.
    Wang G; Tan Y; Jiang Y; Liu J; Su Y; Sun Z; Liu B
    Risk Manag Healthc Policy; 2023; 16():1259-1271. PubMed ID: 37456825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of blood lipids on patients treated with oxaliplatin combined with S-1 (SOX) after radical gastrectomy and establishment of prognostic nomogram.
    Wang S; Chen C; Zhang J; Li J; Qin Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10293-10305. PubMed ID: 37270732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomograms for gastric carcinoma after D2 + total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression.
    Li Y; Bai M; Gao Y
    World J Surg Oncol; 2023 Jul; 21(1):207. PubMed ID: 37475024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
    He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
    World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nomogram to predict the overall survival of postoperative patients with gastric signet.
    Liu D; Ding R; Wang L; Shi E; Li X; Zhang C; Zhang Y; Wang X
    BMC Gastroenterol; 2023 Aug; 23(1):284. PubMed ID: 37587418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.
    Jiang Y; Li T; Liang X; Hu Y; Huang L; Liao Z; Zhao L; Han Z; Zhu S; Wang M; Xu Y; Qi X; Liu H; Yang Y; Yu J; Liu W; Cai S; Li G
    JAMA Surg; 2017 Jul; 152(7):e171087. PubMed ID: 28538950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research.
    Deng ZJ; Nie RC; Lu J; Chen XJ; Xiang J; Huang CM; Chen YB; Peng JS; Chen S
    BMC Gastroenterol; 2021 Oct; 21(1):363. PubMed ID: 34620108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
    Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
    Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A nomogram for predicting lymph node metastasis in early gastric cancer].
    Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
    [No Abstract]   [Full Text] [Related]  

  • 14. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy.
    Shi L; Wang Z; Wang L; Jia Y; Li J; Qin Y
    Cancer Manag Res; 2022; 14():287-301. PubMed ID: 35115828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta computed tomography radiomics features-based nomogram predicts long-term efficacy after neoadjuvant chemotherapy in advanced gastric cancer.
    Shen LL; Zheng HL; Ding FH; Lu J; Chen QY; Xu BB; Xue Z; Lin J; Huang CM; Zheng CH
    Radiol Med; 2023 Apr; 128(4):402-414. PubMed ID: 36940007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 19. Multi‑institutional development and validation of a nomogram to predict prognosis of early-onset gastric cancer patients.
    Liu H; Li Z; Zhang Q; Li Q; Zhong H; Wang Y; Yang H; Li H; Wang X; Li K; Wang D; Kong X; He Z; Wang W; Wang L; Zhang D; Xu H; Yang L; Chen Y; Zhou Y; Xu Z
    Front Immunol; 2022; 13():1007176. PubMed ID: 36148218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter study.
    Huang ZN; Desiderio J; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
    BMC Gastroenterol; 2019 Dec; 19(1):205. PubMed ID: 31791240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.